List of Tables
Table 1. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drug Eluting Guidewire Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drug Eluting Guidewire Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drug Eluting Guidewire Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drug Eluting Guidewire Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drug Eluting Guidewire Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Guidewire, Product Types and Applications
Table 12. Global Key Manufacturers of Drug Eluting Guidewire, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Guidewire Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Guidewire Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 18. Global Drug Eluting Guidewire Sales Market Share by Region (2021–2026)
Table 19. Global Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 20. Global Drug Eluting Guidewire Sales Market Share by Region (2027–2032)
Table 21. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drug Eluting Guidewire Revenue Market Share by Region (2021–2026)
Table 23. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drug Eluting Guidewire Revenue Market Share by Region (2027–2032)
Table 25. North America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 27. North America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 28. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 32. Europe Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 33. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drug Eluting Guidewire Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 42. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 43. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drug Eluting Guidewire Sales (K Units) by Type (2021–2026)
Table 51. Global Drug Eluting Guidewire Sales (K Units) by Type (2027–2032)
Table 52. Global Drug Eluting Guidewire Sales Market Share by Type (2021–2026)
Table 53. Global Drug Eluting Guidewire Sales Market Share by Type (2027–2032)
Table 54. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drug Eluting Guidewire Revenue Market Share by Type (2021–2026)
Table 57. Global Drug Eluting Guidewire Revenue Market Share by Type (2027–2032)
Table 58. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drug Eluting Guidewire Sales (K Units) by Application (2021–2026)
Table 61. Global Drug Eluting Guidewire Sales (K Units) by Application (2027–2032)
Table 62. Global Drug Eluting Guidewire Sales Market Share by Application (2021–2026)
Table 63. Global Drug Eluting Guidewire Sales Market Share by Application (2027–2032)
Table 64. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drug Eluting Guidewire Revenue Market Share by Application (2021–2026)
Table 67. Global Drug Eluting Guidewire Revenue Market Share by Application (2027–2032)
Table 68. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Abbott Drug Eluting Guidewire Product
Table 74. Abbott Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boston Scientific Drug Eluting Guidewire Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Medtronic Drug Eluting Guidewire Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Svelte Medical Systems Company Information
Table 86. Svelte Medical Systems Description and Business Overview
Table 87. Svelte Medical Systems Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Svelte Medical Systems Drug Eluting Guidewire Product
Table 89. Svelte Medical Systems Recent Developments/Updates
Table 90. Terumo Company Information
Table 91. Terumo Description and Business Overview
Table 92. Terumo Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Terumo Drug Eluting Guidewire Product
Table 94. Terumo Recent Developments/Updates
Table 95. Micro-Port Scientific Company Information
Table 96. Micro-Port Scientific Description and Business Overview
Table 97. Micro-Port Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Micro-Port Scientific Drug Eluting Guidewire Product
Table 99. Micro-Port Scientific Recent Developments/Updates
Table 100. Aachen Resonance Company Information
Table 101. Aachen Resonance Description and Business Overview
Table 102. Aachen Resonance Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Aachen Resonance Drug Eluting Guidewire Product
Table 104. Aachen Resonance Recent Developments/Updates
Table 105. Biosensors International Company Information
Table 106. Biosensors International Description and Business Overview
Table 107. Biosensors International Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Biosensors International Drug Eluting Guidewire Product
Table 109. Biosensors International Recent Developments/Updates
Table 110. Biotronik Company Information
Table 111. Biotronik Description and Business Overview
Table 112. Biotronik Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Biotronik Drug Eluting Guidewire Product
Table 114. Biotronik Recent Developments/Updates
Table 115. Cardionovum Company Information
Table 116. Cardionovum Description and Business Overview
Table 117. Cardionovum Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cardionovum Drug Eluting Guidewire Product
Table 119. Cardionovum Recent Developments/Updates
Table 120. eucatech Company Information
Table 121. eucatech Description and Business Overview
Table 122. eucatech Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. eucatech Drug Eluting Guidewire Product
Table 124. eucatech Recent Developments/Updates
Table 125. Eurocor Company Information
Table 126. Eurocor Description and Business Overview
Table 127. Eurocor Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Eurocor Drug Eluting Guidewire Product
Table 129. Eurocor Recent Developments/Updates
Table 130. iVascular Company Information
Table 131. iVascular Description and Business Overview
Table 132. iVascular Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. iVascular Drug Eluting Guidewire Product
Table 134. iVascular Recent Developments/Updates
Table 135. Laborie Medical Technologies Company Information
Table 136. Laborie Medical Technologies Description and Business Overview
Table 137. Laborie Medical Technologies Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Laborie Medical Technologies Drug Eluting Guidewire Product
Table 139. Laborie Medical Technologies Recent Developments/Updates
Table 140. Lepu Medical Company Information
Table 141. Lepu Medical Description and Business Overview
Table 142. Lepu Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Lepu Medical Drug Eluting Guidewire Product
Table 144. Lepu Medical Recent Developments/Updates
Table 145. Spectranetics Company Information
Table 146. Spectranetics Description and Business Overview
Table 147. Spectranetics Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Spectranetics Drug Eluting Guidewire Product
Table 149. Spectranetics Recent Developments/Updates
Table 150. Cook Medical Company Information
Table 151. Cook Medical Description and Business Overview
Table 152. Cook Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Cook Medical Drug Eluting Guidewire Product
Table 154. Cook Medical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Drug Eluting Guidewire Distributors List
Table 158. Drug Eluting Guidewire Customers List
Table 159. Drug Eluting Guidewire Market Trends
Table 160. Drug Eluting Guidewire Market Drivers
Table 161. Drug Eluting Guidewire Market Challenges
Table 162. Drug Eluting Guidewire Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Eluting Guidewire
Figure 2. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drug Eluting Guidewire Market Share by Type: 2025 & 2032
Figure 4. Drug-coated Guidewire Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Drug Eluting Guidewire Market Share by Application: 2025 & 2032
Figure 8. Coronary Intervention
Figure 9. Neurointervention
Figure 10. Other
Figure 11. Global Drug Eluting Guidewire Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drug Eluting Guidewire Market Size (US$ Million), 2021–2032
Figure 13. Global Drug Eluting Guidewire Sales (K Units), 2021–2032
Figure 14. Global Drug Eluting Guidewire Average Price (US$/Unit), 2021–2032
Figure 15. Drug Eluting Guidewire Report Years Considered
Figure 16. Drug Eluting Guidewire Sales Share by Manufacturers in 2025
Figure 17. Global Drug Eluting Guidewire Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Drug Eluting Guidewire Players: Market Share by Revenue in Drug Eluting Guidewire in 2025
Figure 19. Drug Eluting Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 22. North America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 23. United States Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 26. Europe Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 27. Germany Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Drug Eluting Guidewire Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Drug Eluting Guidewire Revenue Market Share by Region (2021–2032)
Figure 34. China Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 42. Latin America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 53. Global Revenue Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 54. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 56. Global Revenue Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 57. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2032)
Figure 58. Drug Eluting Guidewire Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
